RecruitingNCT01366404
Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
A Multicenter, Prospective Cohort to Evaluate the Natural History of FFR Guided Percutaneous Coronary Intervention
Sponsor
Seung-Jung Park
Enrollment
20,000 participants
Start Date
Jun 1, 2011
Study Type
OBSERVATIONAL
Conditions
Summary
About 20,000 patients with FFR (Fractional Flow Reserve) will be enrolled and evaluated for the natural history of coronary lesions at 2 years clinical and imaging follow-up.
Eligibility
Min Age: 35 Years
Inclusion Criteria3
- Age 35 years and older
- FFR measurement on one and more coronary artery stenosis
- Willing and able to provide informed, written consent
Exclusion Criteria10
- Stenosis with TIMI<3 flow
- Graft vessel
- Ejection fraction < 30%
- Angiographic evidence of extreme tortuosity or calcified coronary vessels
- Suspected coronary spasm even after sufficient nitrate injected
- Life expectancy <2 year
- Planned cardiac surgery or planned major non cardiac surgery
- Woman who are breastfeeding, pregnant or planning to become pregnant during the course of the study
- visually-estimated angiographic reference segment diameter of <2.75mm or >4.0mm
- Inappropriate for IVUS/VH/OCT procedures : inability for imaging wire or catheter to pass through the tight stenosis, severe calcification, angulation
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(29)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01366404
Related Trials
Product Surveillance Registry
NCT01524276395 locations
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
NCT072582901 location
DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
NCT0665783313 locations
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
NCT0686315512 locations
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NCT0719069016 locations